FDA
approval
· 2020-11-20
FDA Approved: SEVELAMER CARBONATE — Original Application (Amneal Pharmaceuticals of New York LLC)
Summary
FDA approved Amneal Pharmaceuticals of New York LLC's generic sevelamer carbonate for the management of hyperphosphatemia in patients with chronic kidney diseas…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)